Fagron obtains regulatory clearance for the acquisition of Vepakum in Brazil and completes the acquisition of Magilab in Hungary

Group 1 - Fagron has obtained regulatory clearance for the acquisition of Vepakum in Brazil and has completed the acquisition of Magilab in Hungary [1][9] - The acquisition of Vepakum will enable Fagron to enter a new vertical in high-quality packaging solutions, providing scale benefits through joint packaging, distribution, and shared services [2] - The acquisition of Magilab strengthens Fagron's position in Hungary's hospital pharmacy segment, which has a high compounding per capita, and supports operational leverage through integration and scale [3] Group 2 - Fagron is a leading global company in pharmaceutical compounding, focusing on personalized medicine delivery to hospitals, pharmacies, clinics, and patients in over 35 countries [5] - The company is based in Nazareth, Belgium, and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol 'FAGR' [6]